Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Amdipharm UK Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
Phenylephrine 10 mg/ml Injection.
| Pharmaceutical Form |
|---|
|
A clear, colourless liquid, free from extraneous visible particles. |
Each 1 ml ampoule contains 10 mg of the active ingredient phenylephrine hydrochloride.
Excipients with known effect: Sodium hydroxide solution (q.s.- quantity per ml)
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Phenylephrine |
Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion. |
| List of Excipients |
|---|
|
Sodium hydroxide solution 1N |
1 ml neutral glass ampoule with red imprint break ring.
Pack size: 6 × 1ml and 10 × 1ml ampoules.
Not all pack sizes may be marketed.
Amdipharm UK Limited, Capital House, 85 King William Street, London EC4N 7BL, UK
PL 20072/0226
Date of first authorisation: 17 November 1999
Date of latest renewal: 18 November 2005
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
